Eric L. Matteson

54.3k total citations · 8 hit papers
465 papers, 25.5k citations indexed

About

Eric L. Matteson is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Eric L. Matteson has authored 465 papers receiving a total of 25.5k indexed citations (citations by other indexed papers that have themselves been cited), including 273 papers in Rheumatology, 206 papers in Pulmonary and Respiratory Medicine and 71 papers in Physiology. Recurrent topics in Eric L. Matteson's work include Rheumatoid Arthritis Research and Therapies (142 papers), Vasculitis and related conditions (126 papers) and Systemic Lupus Erythematosus Research (94 papers). Eric L. Matteson is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (142 papers), Vasculitis and related conditions (126 papers) and Systemic Lupus Erythematosus Research (94 papers). Eric L. Matteson collaborates with scholars based in United States, United Kingdom and Germany. Eric L. Matteson's co-authors include Cynthia S. Crowson, Sherine E. Gabriel, Tim Bongartz, Kenneth J. Warrington, Carl Turesson, John M. Davis, Jay H. Ryu, Patompong Ungprasert, Gene G. Hunder and Michael Sweeting and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Investigation.

In The Last Decade

Eric L. Matteson

456 papers receiving 24.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies

2006 1.9k citations Eric L. Matteson et al. profile →
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

2015 655 citations Eric L. Matteson et al. profile →
An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis

2016 602 citations John M. Davis, Eric L. Matteson et al. profile →
Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population‐based study

2010 584 citations Carlotta Nannini, Sara J. Achenbach et al. profile →
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial

2009 423 citations Jonathan Kay, Eric L. Matteson et al. profile →
The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases

2010 402 citations Cynthia S. Crowson, Eric L. Matteson et al. profile →
Polymyalgia Rheumatica and Giant Cell Arteritis

2016 305 citations Frank Buttgereit, Christian Dejaco et al. profile →
Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985–2014

2020 180 citations Elena Myasoedova, John M. Davis et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by Eric L. Matteson

Since Specialization

Citations

This map shows the geographic impact of Eric L. Matteson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric L. Matteson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric L. Matteson more than expected).

Fields of papers citing papers by Eric L. Matteson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric L. Matteson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric L. Matteson. The network helps show where Eric L. Matteson may publish in the future.

Co-authorship network of co-authors of Eric L. Matteson

This figure shows the co-authorship network connecting the top 25 collaborators of Eric L. Matteson. A scholar is included among the top collaborators of Eric L. Matteson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric L. Matteson. Eric L. Matteson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recommendations of the German, Austrian and Swiss rheumatology and other medical societies for the management of polymyalgia rheumatica 2025 ·Lara D. Veeken ·Frank Buttgereit, (unknown), (unknown), (unknown), (unknown), Thomas Daikeler, Christina Duftner, (unknown), Ulrike Garske, Bernhard Hellmich, Diego Kyburz, Anett Reißhauer, Monika Reuß‐Borst, Kathrin Scheuermann, (unknown), Eric L. Matteson, Christian Dejaco	0
2	Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review 2023 ·RMD Open ·Eric L. Matteson, Marco Matucci‐Cerinic, Michael Kreuter, Gerd R Burmester, Philippe Dieudé, Paul Emery, Yannick Allanore, Janet Pope, Dinesh Khanna	6
3	Decline in Incidence of Extra‐Articular Manifestations of Rheumatoid Arthritis: A Population‐Based Cohort Study 2023 ·Arthritis Care & Research ·(unknown), Cynthia S. Crowson, John M. Davis, Eric L. Matteson, Elena Myasoedova	7
4	Glucocorticoids Are Not Associated with Bone Mineral Density in Patients with Polymyalgia Rheumatica, Giant Cell Arteritis and Other Vasculitides—Cross-Sectional Baseline Analysis of the Prospective Rh-GIOP Cohort 2022 ·Cells ·Andriko Palmowski, (unknown), Burkhard Muche, Sandra Hermann, Christian Dejaco, Eric L. Matteson, Frank Buttgereit	5
5	Increased Risk of Valvular Heart Disease in Systemic Sclerosis: An Underrecognized Cardiac Complication 2021 ·The Journal of Rheumatology ·Reto Kurmann, Edward El‐Am, Yasser Radwan, (unknown), Cynthia S. Crowson, Eric L. Matteson, (unknown), Rekha Mankad, Ashima Makol	13
6	A novel humanized model of rheumatoid arthritis associated lung disease 2021 ·Clinical Immunology ·Lin Li, (unknown), David Luckey, Shaohua Wang, Faping Wang, Jessica Lau, Kenneth J. Warrington, Eric L. Matteson, Robert Vassallo, Veena Taneja	6
7	Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica 2020 ·Nature Reviews Rheumatology ·Dario Camellino, Eric L. Matteson, Frank Buttgereit, Christian Dejaco	58
8	Hospitalization Rates Are Highest in the First 5 Years of Systemic Sclerosis: Results From a Population-based Cohort (1980–2016) 2020 ·The Journal of Rheumatology ·(unknown), (unknown), Cynthia S. Crowson, Sara J. Achenbach, Eric L. Matteson, Thomas G. Osborn, (unknown), Ashima Makol	7
9	Author Correction: Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica 2020 ·Nature Reviews Rheumatology ·Dario Camellino, Eric L. Matteson, Frank Buttgereit, Christian Dejaco	2
10	Association of Smoking and Obesity on the Risk of Developing Primary Sjögren Syndrome: A Population-based Cohort Study 2019 ·The Journal of Rheumatology ·(unknown), Gabriel Maciel, Carlotta Nannini, Cynthia S. Crowson, Eric L. Matteson, (unknown), Alvise Berti	10
11	2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis 2019 ·Annals of the Rheumatic Diseases ·Lisa Ehlers, Johan Askling, (unknown), (unknown), Maurizio Cutolo, Bhaskar Dasgupta, Christian Dejaco, William G Dixon, Nils Feltelius, Axel Finckh, Kate Gilbert, Sarah Mackie, Alfred Mahr, Eric L. Matteson, Lorna Neill, Carlo Salvarani, Wolfgang Schmidt, Anja Strangfeld, Ronald van Vollenhoven, Frank Buttgereit	57
12	Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort 2018 ·Nephrology Dialysis Transplantation ·Alvise Berti, Émilie Cornec-Le Gall, Divi Cornec, Marta Casal Moura, Eric L. Matteson, Cynthia S. Crowson, Aishwarya Ravindran, Sanjeev Sethi, Fernando C. Fervenza, Ulrich Specks	54
13	Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) 2018 ·Annals of the Rheumatic Diseases ·Désirée van der Heijde, David Daikh, Neil Betteridge, Gerd R Burmester, Afton L. Hassett, Eric L. Matteson, Ronald van Vollenhoven, Sharad Lakhanpal	38
14	Risk of fragility fracture among patients with sarcoidosis: a population-based study 1976–2013 2017 ·Osteoporosis International ·Patompong Ungprasert, Cynthia S. Crowson, Eric L. Matteson	15
15	Influence of Gender on Epidemiology and Clinical Manifestations of Sarcoidosis: A Population-Based Retrospective Cohort Study 1976–2013 2016 ·Lung ·Patompong Ungprasert, Cynthia S. Crowson, Eric L. Matteson	45
16	A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages 2008 ·Blood ·Wei Xia, (unknown), Eric L. Matteson, (unknown), Ji‐Xin Cheng, Philip S. Low	265
17	Improvement in DAS28 response through one-year of golimumab treatment in patients with active RA despite treatment with methotrexate: A phase II, randomized, double blind, placebo controlled, dose ranging trial 2007 ·Annals of the Rheumatic Diseases ·Jonathan Kay, Patrick Durez, Eric L. Matteson, B. Dasgupta, Peter Nash, Stephen Hall, E. C. Hsia, (unknown), Jia Han, Mahboob U. Rahman	2
18	Comparison of disease activity measures for ANCA-associated vasculitis. 2004 ·Oxford University Research Archive (ORA) (University of Oxford) ·Peter A. Merkel, David Cuthbertson, (unknown), G S Hoffman, David Jayne, (unknown), Jeffrey Krischer, Raashid Luqmani, Alfred Mahr, Eric L. Matteson, Ulrich Specks, John H. Stone	4
19	Fatal Sepsis in a Patient With Rheumatoid Arthritis Treated With Etanercept 2001 ·Mayo Clinic Proceedings ·Mercedeh Baghai, Douglas R. Osmon, Donna M. Wolk, Lester E. Wold, George J. Haidukewych, Eric L. Matteson	103
20	Fatal Sepsis in a Patient With Rheumatoid Arthritis Treated With Etanercept 2001 ·Mayo Clinic Proceedings ·Mercedeh Baghai, Douglas R. Osmon, Donna M. Wolk, Lester E. Wold, George J. Haidukewych, Eric L. Matteson	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact